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The KEAP1/NRF2/ARE pathway and the heat shock
response are inducible cytoprotective systems regu-
lated by transcription factors NRF2 and HSF1,
respectively. We report that structurally distinct
small molecule NRF2 activators, all of which react
with sulfhydryl groups but differ in potency by
15,000-fold, upregulate Hsp70, a prototypic HSF1-
dependent gene. Hsp70 upregulation requires HSF1
but is NRF2 independent. We further demonstrate
that a sulfoxythiocarbamate inducer conjugates to
the negative regulator of HSF1, Hsp90. The differen-
tial concentration dependence of the two responses
suggests that activation of NRF2 precedes that of
HSF1: the KEAP1/NRF2/ARE pathway is at the fore-
front of cellular defense, protecting against instant
danger; the heat shock response closely follows to
resolve subsequent potentially devastating damage,
saving the proteome. This uncovered duality un-
doubtedly contributes to the cytoprotective effects
of such molecules in models of carcinogenesis,
cardiovascular disease, and neurodegeneration.
INTRODUCTION
Eukaryotic organisms have evolved highly efficient protective
mechanisms that enable their survival under conditions of stress.
Most prominent are the heat shock response and the KEAP1/
NRF2/ARE pathway, known as ‘‘the electrophile counterattack
response.’’ There is a growing interest in the discovery and
development of small molecule inducers of these systems for
prevention and treatment of chronic degenerative disease (Tala-
lay, 2000; Westerheide and Morimoto, 2005). Induction leads to
upregulation of large networks of cytoprotective proteins that
detect, prevent, and counteract the consequences of thermal,Chemistry & Biology 18, 1355–136oxidative, and electrophilic stress, and promote survival.
Furthermore, both responses are involved in multiple interac-
tions that link homeostatic metabolism with stress biology, and
they ultimately play crucial roles in determining health and life
span (Akerfelt et al., 2010; Wakabayashi et al., 2010).
The heat shock response and the KEAP1/NRF2/ARE pathway
are controlled by two central regulators, heat shock factor 1
(HSF1) and nuclear factor-erythroid 2-related factor 2 (NRF2),
respectively. Under homeostatic conditions, HSF1 is an inactive
monomer bound to heat shock protein 90 (Hsp90). Following
stimulation, HSF1 dissociates from the Hsp90 complex, trimer-
izes, and binds to heat shock elements (HSEs) of its target
genes, thereby driving their expression (Westerheide and
Morimoto, 2005). In addition a number of posttranslational modi-
fications, such as phosphorylation, acetylation, and sumoyla-
tion, are involved in regulating the transcriptional activity of
HSF1, and there is also negative feedback regulation by heat
shock proteins (Akerfelt et al., 2010). NRF2, under basal condi-
tions, is targeted for ubiquitination and proteasomal degradation
by its repressor KEAP1 (Kelch-like ECH-associated protein 1).
Inducers, all of which possess a single common chemical
property, i.e., reactivity with sulfhydryl groups (Talalay et al.,
1988), chemically react with KEAP1, rendering it unable to
repress NRF2, permitting the nuclear translocation of the tran-
scription factor that binds to antioxidant response elements
(AREs) as a heterodimer with a small Maf protein, driving expres-
sion of target genes (Motohashi and Yamamoto, 2004).
Activation of NRF2 counteracts oxidative and electrophilic
stress; activation of HSF1 prevents protein misfolding. Due to
the versatility of their target genes, the combined action of these
transcription factors allows for maintenance of normal cellular
functions under various stress conditions. Conversely, their
suppression results in accelerated pathogenesis in numerous
models of disease. Therefore, it is rather curious that in addition
to thermal stress, environmental redox changes and electro-
philes also induce heat shock genes. Thus, murine HSF1 is acti-
vated by H2O2 in a manner dependent on C35 and C105 (Ahn
and Thiele, 2003). Similarly, an intermolecular disulfide bond
between C36 and C103 within human HSF1 causes trimerization1, November 23, 2011 ª2011 Elsevier Ltd All rights reserved 1355
OOH
O
HO
H
  µ
A B
C
Figure 1. Induction of NQO1, HO-1, and Hsp70 by Celastrol
(A) Chemical structure of celastrol.
(B) Hepa 1c1c7 cells (104 per well) in 96-well plates were exposed to serial
dilutions of the quinone methide triterpenoid celastrol. NQO1 activity was
measured 48 hr later in cell lysates. Results are mean values (n = 8). The SD in
each case was <10%of the value. CD, Concentration that doubles the specific
activity of NQO1.
(C) Wild-type (WT) or HSF1-knockout (KO) MEFs (2 3 105 per well) in 6-well
plates were exposed to vehicle (0.1% DMSO) or increasing concentrations
of celastrol (CL) for 4 hr. Cells were lysed in RIPA buffer 20 hr later, aliquots
from cell lysates were resolved by SDS/PAGE, transferred to immobilon-P,
and probed with antibodies against Hsp70 (StressMarq Biosciences Inc.;
1:1000 dilution), HO-1 (Enzo Life Sciences; 1:1000 dilution), and NQO1 (1:3000
dilution; a kind gift from John D. Hayes, University of Dundee). The antibody
against glyceraldehyde-3-phosphate dehydrogenase (GAPDH, Sigma-
Aldrich; 1:5000 dilution) was used as a loading control. The data are repre-
sentative of two independent experiments.
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HSF1-Dependent Activation of Hsp70 by Nrf2 Inducerand DNA binding, whereas an intramolecular disulfide bridge (in
which C153, C373, and C378 participate) is inhibitory (Lu et al.,
2008). The electrophilic nitro-oleic acid (but not the nonelectro-
philic oleic acid), the cyclopentenone (but not the cyclopenta-
none) prostaglandins, the triterpenoid celastrol, the isothiocya-
nate sulforaphane, and dithiolethione, all of which possess
cysteine reactivity, are activators of both HSF1- and NRF2-
dependent genes (Kwak et al., 2004; Westerheide and Mori-
moto, 2005; Trott et al., 2008; Kansanen et al., 2009; Gan
et al., 2010). Therefore, we hypothesized that a common signal
that is sensed through cysteine modification(s) within KEAP1
and HSF1, or a negative regulator of HSF1, serves as a trigger
for both cytoprotective pathways. To test this hypothesis, we
asked: (1) Do NRF2 activators that differ in their chemical struc-
tures, but share reactivity with sulfhydryl groups, also induce
Hsp70, a prototypic HSF1-target gene?; and (2) Is the ability to
upregulate Hsp70 mediated by transcription factors HSF1,
NRF2, or both?
RESULTS AND DISCUSSION
Celastrol, an Electrophilic Quinone Methide, Induces
NRF2- and HSF1-Dependent Genes
Using a quantitative bioassay (Prochaska and Santamaria,
1988), we identified among a large series of synthetic pentacy-
clic triterpenoids and tricyclic bis(cyanoenone)s the most potent
(active at sub- to low-nanomolar concentrations) NRF2 activa-
tors known to date (Dinkova-Kostova et al., 2005, 2010). Struc-
ture-activity studies established the essential requirement for
electrophilic Michael acceptor group(s) for inducer activity.
Based on this finding, we predicted that celastrol, a naturally
occurring triterpenoid that has an electrophilic quinone methide
functionality (Figure 1A), will be an inducer. Indeed, we found
a potent dose-dependent induction of NAD(P)H:quinone oxido-
reductase 1 (NQO1), a prototypic NRF2-dependent enzyme,
by celastrol with a CD (concentration that doubles the specific
activity of the enzyme) of 0.2 mM (Figure 1B). Notably, celastrol
is a classical HSF1 activator and inducer of the heat shock
response (Westerheide and Morimoto, 2005; Trott et al., 2008).
In close agreement we found a coordinate dose-dependent
upregulation of Hsp70 and heme oxygenase 1 (HO-1), also
known as Hsp32, when mouse embryonic fibroblasts (MEFs)
were exposed to celastrol (Figure 1C).
To investigate the role of HSF1 in the mechanism of induction
of Hsp70 and HO-1, we used MEFs isolated from HSF1-
knockout mice (Xiao et al., 1999). In contrast to their wild-type
counterparts, no induction of Hsp70 was observed in HSF1-defi-
cient cells, demonstrating the essential requirement for HSF1 for
upregulation of this heat shock protein (Figure 1C). Curiously, the
basal levels of HO-1 and NQO1 were higher in HSF1-knockout
MEFs. However, unlike Hsp70, HO-1 and NQO1 were upregu-
lated independently of HSF1, implying alternative complemen-
tary mechanism(s) in their induction by celastrol.
HSF1-Mediated Upregulation of Hsp70 Is a Common
Property of Inducers of the KEAP1/NRF2/ARE Pathway
Because NQO1 gene expression is mediated by NRF2, whereas
expression of Hsp70 is controlled by HSF1, it appears that
celastrol activates both transcription factors. To test whether1356 Chemistry & Biology 18, 1355–1361, November 23, 2011 ª2011upregulation of the heat shock response might be a common
property of activators of the KEAP1/NRF2/ARE pathway, we
exposed MEFs to three structurally distinct compounds, i.e.,
the double Michael acceptor bis(2-hydroxybenzylidene)acetone
(HBB2), the tricyclic bis(cyanoenone)-31 (TBE-31), and the
sulfoxythiocarbamate-alkyne STCA (Figure 2A). In addition we
examined the effects of the nonhydroxylated analog of HBB2,
bis(benzylidene)acetone (DBA), which, although structurally
similar, is 100-fold less potent as an NQO1 inducer than HBB2
in Hepa1c1c7 cells (Dinkova-Kostova et al., 2001). Of note,Elsevier Ltd All rights reserved
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Figure 2. Induction of Hsp70 by Inducers of the KEAP1/NRF2/ARE Pathway Depends on HSF1 but Is Independent of NRF2
(A) Chemical structures of DBA, HBB2, TBE-31, and STCA. Wild-type (B, D, and E), HSF1-knockout (C), NRF2-knockout (D), or KEAP1-knockout (E) MEFs
(2 3 105 per well) in 6-well plates were exposed to vehicle (0.1% acetonitrile), DBA, HBB2, celastrol (CL), TBE-31, or STCA for 4 hr. The levels of Hsp70, HO-1,
and NQO1 were evaluated by western blot 20 hr later. Of note, the STCA-treated sample in (B) and (C) was run on the same gel, but the lane between ‘‘TBE-31’’
and ‘‘STCA’’ was pulled out. The data are representative of three independent experiments.
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HSF1-Dependent Activation of Hsp70 by Nrf2 Inducerbecause of the lower sensitivity and semiquantitative nature of
the western blot in comparison with the highly sensitive and
quantitative enzyme assay, in the experiments described inChemistry & Biology 18, 1355–136this paper, we used saturating concentrations of these inducers
with respect to upregulation of NQO1. Our choice of compounds
was determined by the following considerations: (1) they have1, November 23, 2011 ª2011 Elsevier Ltd All rights reserved 1357
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HSF1-Dependent Activation of Hsp70 by Nrf2 Inducerdistinct chemical structures; (2) they react with sulfhydryl groups;
and (3) they differ enormously (by 15,000-fold) in inducer
potency: TBE-31 (CD = 0.9 nM) being the most potent, and
DBA (CD = 15 mM) being the least potent. HBB2, TBE-31, and
STCA inducedHsp70, HO-1, andNQO1 (Figure 2B). Importantly,
as was found for celastrol, induction of Hsp70, but not of HO-1
or NQO1, by all compounds examinedwas completely abolished
in HSF1-knockout cells, supporting the essential role played by
HSF1 in upregulation of Hsp70 (Figure 2C).
HBB2, TBE-31, and STCA react readily with cysteine residues
of KEAP1, leading to activation of NRF2 and induction of its
downstream target genes, including NQO1 (Liby et al., 2008;
Dinkova-Kostova et al., 2002; 2010; Ahn et al., 2010). Further-
more, there is a correlation between reactivity with sulfhydryl
groups and NQO1-inducer potency (Talalay et al., 1988;
Dinkova-Kostova et al., 2001). In the experiments described
in this report, we were guided by our prior knowledge of the
reactivity of each compound with sulfhydryl groups when
selecting the dose to use. Thus, despite their structural similarity,
HBB2 and DBA differ greatly in their reactivity with sulfhydryl
groups: the second-order rate constant for the reaction with
glutathione is30-fold higher for HBB2 than for DBA, correlating
with the 100-fold greater NQO1-inducer potency of HBB2
(Dinkova-Kostova et al., 2001). The profound difference in
the ability of this pair of compounds to induce Hsp70 and the
essential requirement for HSF1 strongly suggest that, similar to
activation of NRF2, cysteine reactivity is also critical for activa-
tion of HSF1.
Upregulation of Hsp70 by Inducers of the
KEAP1/NRF2/ARE Pathway Is Independent of NRF2
The Keap1/Nrf2/ARE pathway is a validated target for HBB2,
DBA, and STCA. Induction of NQO1 by these compounds is
dependent on NRF2 and does not occur in cells that are deficient
for this transcription factor (Liu et al., 2008; Ahn et al., 2010).
Therefore, we investigated its potential contribution to induction
of Hsp70 and HO-1 by comparing MEFs isolated from NRF2-
knockout mice or their wild-type counterparts. Induction of
Hsp70 was identical in both cell types upon exposure to
HBB2, celastrol, or STCA, establishing that NRF2 is dispensable
for upregulation of Hsp70 (Figure 2D). Importantly, no Hsp70
induction was observed when cells of either genotype were
treated with DBA. In comparison to wild-type MEFs, HO-1, but
not NQO1, induction by HBB2, celastrol, and STCA still occurred
in NRF2-knockout cells, although to a lower degree (Figure 2D),
and was not evident in NRF2-knockout cells exposed to DBA.
The results show that: (1) induction of NQO1 by these
compounds is fully dependent on NRF2, (2) NRF2 is partially
responsible for the upregulation of HO-1, and (3) induction of
Hsp70 is clearly independent of this transcription factor.
MEFs that are deficient in KEAP1, the negative regulator of
NRF2, constitutively express high levels of NRF2 target genes
and are resistant to the toxicities of xenobiotics (Kwak et al.,
2004). We next compared the expression levels of Hsp70 and
HO-1 in KEAP1-knockout MEFs to those in their wild-type coun-
terparts following exposure to DBA, HBB2, celastrol, or STCA.
In sharp contrast with wild-type cells, induction of Hsp70 in
KEAP1-knockout cells was observed only by HBB2, although
even in this case it was quite diminished (Figure 2E). In the1358 Chemistry & Biology 18, 1355–1361, November 23, 2011 ª2011absence of KEAP1, the levels of NQO1 were constitutively upre-
gulated and not affected by inducers. In contrast the basal levels
of HO-1 were only slightly higher in KEAP1-knockout cells, sup-
porting the conclusion that, in this cell type, transcription factor
NRF2 is not the major contributor to the gene expression of
this cytoprotective protein. Induction of HO-1 was also reduced
under conditions of constitutive NRF2 upregulation, with the
same exception, induction by HBB2. The results suggest
that the bioavailability of these compounds for their protein
targets is lower in KEAP1-knockout MEFs, most likely due to
more efficient metabolism and excretion. Indeed, cells and
animals that lack KEAP1 overexpress a plethora of drug-meta-
bolizing enzymes and efflux pumps (Kwak et al., 2004; Yates
et al., 2009).
STCA Covalently Binds to Hsp90
Our results indicate that reactivity with cysteine(s) plays a critical
role in the mechanism of HSF1 activation. Therefore, it is
tempting to speculate that, similar to the KEAP1/NRF2/ARE
pathway, a common signal that is sensed through cysteine
modification(s) within HSF1, or a negative regulator of HSF1, trig-
gers the heat shock response. Notably, induction of NRF2-
dependent genes occurs at lower inducer concentrations than
those that cause upregulation of Hsp70. Thus, the concentration
that doubles (CD value) the activity of NQO1 for STCA, celastrol,
HBB2, and TBE-31 is 5.5, 0.2, 0.15, and 0.0009 mM, respectively
(Ahn et al., 2010; Dinkova-Kostova et al., 2001, 2010). Although
it is not possible to compare directly a highly quantitative
enzymatic assay with semiquantitative western blot analysis,
induction of HO-1, as judged by our western blots, requires
concentrations that are similar to those that induce NQO1. In
contrast, upregulation of Hsp70 becomes apparent when cells
are exposed to 25 mM STCA, 0.8 mM celastrol, 1 mM HBB2,
and 0.05 mM TBE-31. One reason could be a difference in the
abundance of the protein targets that lead to activation of
NRF2 and HSF1, respectively. KEAP1, the negative regulator
of NRF2, is a very low abundant protein. In contrast, Hsp90,
a negative regulator of HSF1, is one of themost abundant cellular
proteins. Curiously, by use of a proteomics approach, we previ-
ously identified Hsp90 among the proteins that were modified
when HEK293 cells were exposed to STCA (Ahn et al., 2010).
In this study we validated this finding by immunoprecipitation-
western blot analysis, taking advantage of the stability of the
STCA-cysteine conjugate and its alkyne moiety that allows use
of click chemistry. Thus, Hsp90 was immunoprecipitated from
lysates of HEK293 cells treated with STCA or vehicle, and sub-
jected to click reaction with biotin azide. Immunoblotting with
streptavidin or Hsp90 antibody revealed a clear band migrating
identically to Hsp90 that was present only in lysates from
STCA-treated cells (Figure 3), implying that Hsp90 was cova-
lently modified by STCA.
Exposure to TBE-31, a Dual Inducer of theKEAP1/NRF2/
ARE Pathway and Hsp70, Protects against
Peroxynitrite-Induced Cytotoxicity
The generation of peroxynitrite from the reaction of nitric oxide
with superoxide is critically involved in the pathogenesis of
cardiovasculardisease, diabetes, chronic inflammatorydiseases,
cancer, and neurodegenerative disorders, and the developmentElsevier Ltd All rights reserved
Figure 3. STCA Conjugates on Hsp90
HEK293 cells were grown and exposed to 10 mM STCA or vehicle for 2.5 hr as
described (Ahn et al., 2010). Hsp90 was immunoprecipitated from cell lysates
and subjected to click reaction with biotin azide on beads. Eluted samples
were immunoblotted with streptavidin or Hsp90 antibody (BD Biosciences;
1:1000 dilution). The data are representative of two independent experiments.
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HSF1-Dependent Activation of Hsp70 by Nrf2 Inducerof pharmacological agents that reduce the toxicity of peroxynitrite
is actively being pursued (Pacher et al., 2007). Therefore, we
examined the ability of TBE-31, the most potent inducer in this
series, to protect against the cytotoxicity of the peroxynitriteFigure 4. TBE-31 Protects against Peroxynitrite-Induced Cytotoxicity
Wild-type (A) (1.3 3 104 per well), KEAP1-knockout (B) (0.5 3 104 per well), NRF
HSF1-knockout (E) (1.33 104 per well) MEFs were grown on 96-well plates overni
50 nM TBE-31 (black bars) in complete medium for 4 hr, incubated for a further 20
Hank’s buffered saline solution for 2 hr. Cell viability was assessed by the MTT ass
(n = 4) and representative of two to three independent experiments. The asteris
treated control; *p < 0.01; **p < 0.001.
Chemistry & Biology 18, 1355–136donor, 3-morpholinosydnonimine (SIN-1). Exposure to SIN-1
caused a dose-dependent loss of cell viability. Thus, in wild-
type MEFs, treatment with 8 mM SIN-1 resulted in 80% cell
death (Figure 4A, white bars). Pretreatment with 50 nM TBE-31
24 hr prior to SIN-1 exposure was highly protective, and 80%
of the cells were viable (Figure 4A, black bars). Compared to
wild-type, KEAP1-knockout MEFs were much more resistant
to SIN-1 cytotoxicity, and 65% of the cells were still viable at
8 mM SIN-1 (Figure 4B, white bars), whereas NRF2-knockout
MEFs were very sensitive with 70% cell death occurring at
0.5 mM SIN-1 (Figure 4C, white bars). Importantly, the protective
effect of TBE-31 was essentially abolished in the absence of
either KEAP1 (Figure 4B, black bars) or NRF2 (Figure 4C, black
bars), suggesting that protectionwas primarily due toNRF2 upre-
gulation. In close agreement, although HSF1-knockout MEFs
(Figure 4E, white bars) were more sensitive to SIN-1 than their
wild-type counterparts (Figure 4D, white bars), TBE-31 was
generally protective in both cell types (Figures 4D and 4E, black
bars). However, at 8 mM SIN-1, protection by TBE-31 was
compromised in the HSF1-knockout cells, implying that at high
concentrations (at which cell damage is greatest), the HSF1
pathway also plays a role in the protective mechanisms.2-knockout (C) (1.5 3 104 per well), HSF1-wild-type (D) (0.5 3 104 per well), or
ght. Cells were then treated with either vehicle (0.1% acetonitrile, white bars) or
hr in the absence of TBE-31, and finally exposed to serial dilutions of SIN-1 in
ay following incubation in complete medium 22 hr later. Results are mean ± SD
ks indicate statistically significant differences (Student’s t test) from vehicle-
1, November 23, 2011 ª2011 Elsevier Ltd All rights reserved 1359
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Our results firmly establish that structurally diverse inducers
of the KEAP1/NRF2/ARE pathway, all of which react with
sulfhydryl groups, upregulate Hsp70 in an HSF1-dependent,
but NRF2-independent, manner. Activation of HSF1 occurs at
much higher inducer concentrations than those that activate
NRF2. This observation suggests that activation of NRF2
precedes that of HSF1, and further supports the notion that the
KEAP1/NRF2/ARE pathway is at the forefront of cellular defense
and functions to remove and repair the consequences of instant
danger. The heat shock response then follows to resolve a
potentially devastating damage, save the proteome, and ensure
survival.SIGNIFICANCE
The heat shock response and the KEAP1/NRF2/ARE
pathway provide the cell with carefully orchestrated broad
defense mechanisms by regulating the expression of
networks of several hundred genes that encode proteins
with versatile cytoprotective functions. Deficiencies in these
systems are associated with accelerated pathogenesis of
many chronic degenerative diseases and aging. The identifi-
cation of potent small molecule inducers of these pathways
is being actively pursued as a strategy to prevent or delay
disease onset and to extend healthy life span. Indeed, such
compounds protect against the otherwise detrimental
consequences of the toxic, neoplastic, and proinflammatory
effects of a wide array of xenobiotics and endogenous
substances in numerous experimental models of carcino-
genesis, cardiovascular disease, and neurodegeneration.
By use of a chemical approach, we found that small mole-
cule inducers of the KEAP1/NRF2/ARE pathway that are
structurally distinct, but commonly react with sulfhydryl
groups, also share the ability to upregulate Hsp70 and,
thus, have identified a previously unknown target for these
molecules. Next, by taking a genetic approach and using
cells that are deficient for transcription factors HSF1 or
NRF2, we have obtained mechanistic understanding in that
HSF1 is essential for induction of Hsp70, whereas NRF2 is
dispensable. In addition our results provide a possible
explanation for the cytoprotective effects that have been
attributed to such compounds even in the absence of tran-
scription factor NRF2. Taken together, these findings
support the future development of potent ‘‘dual‘‘ activators
of this type as mechanism-based comprehensive cytopro-
tective agents.
ACKNOWLEDGMENTS
We acknowledge with gratitude the financial support of Research Councils
UK, Cancer Research UK (C20953/A10270), and the NIH (U54 RR020839).
We thank Masayuki Yamamoto (Tohoku University) for NRF2- and KEAP1-
knockout MEFs and John D. Hayes (University of Dundee) for valuable
comments.
Received: March 28, 2011
Revised: August 31, 2011
Accepted: September 1, 2011
Published: November 22, 20111360 Chemistry & Biology 18, 1355–1361, November 23, 2011 ª2011REFERENCES
Ahn, S.G., and Thiele, D.J. (2003). Redox regulation of mammalian heat
shock factor 1 is essential for Hsp gene activation and protection from stress.
Genes Dev. 17, 516–528.
Ahn, Y.H., Hwang, Y., Liu, H., Wang, X.J., Zhang, Y., Stephenson, K.K.,
Boronina, T.N., Cole, R.N., Dinkova-Kostova, A.T., Talalay, P., and Cole,
P.A. (2010). Electrophilic tuning of the chemoprotective natural product sulfor-
aphane. Proc. Natl. Acad. Sci. USA 107, 9590–9595.
Akerfelt, M., Morimoto, R.I., and Sistonen, L. (2010). Heat shock factors: inte-
grators of cell stress, development and lifespan. Nat. Rev. Mol. Cell Biol. 11,
545–555.
Dinkova-Kostova, A.T., Massiah, M.A., Bozak, R.E., Hicks, R.J., and Talalay,
P. (2001). Potency of Michael reaction acceptors as inducers of enzymes
that protect against carcinogenesis depends on their reactivity with sulfhydryl
groups. Proc. Natl. Acad. Sci. USA 98, 3404–3409.
Dinkova-Kostova, A.T., Holtzclaw,W.D., Cole, R.N., Itoh, K., Wakabayashi, N.,
Katoh, Y., Yamamoto, M., and Talalay, P. (2002). Direct evidence that sulfhy-
dryl groups of Keap1 are the sensors regulating induction of phase 2 enzymes
that protect against carcinogens and oxidants. Proc. Natl. Acad. Sci. USA 99,
11908–11913.
Dinkova-Kostova, A.T., Talalay, P., Sharkey, J., Zhang, Y., Holtzclaw, W.D.,
Wang, X.J., David, E., Schiavoni, K.H., Finlayson, S., Mierke, D.F., and
Honda, T. (2010). An exceptionally potent inducer of cytoprotective enzymes:
elucidation of the structural features that determine inducer potency and reac-
tivity with Keap1. J. Biol. Chem. 285, 33747–33755.
Dinkova-Kostova, A.T., Liby, K.T., Stephenson, K.K., Holtzclaw,W.D., Gao, X.,
Suh, N., Williams, C., Risingsong, R., Honda, T., Gribble, G.W., et al. (2005).
Extremely potent triterpenoid inducers of the phase 2 response: correlations
of protection against oxidant and inflammatory stress. Proc. Natl. Acad. Sci.
USA 102, 4584–4589.
Gan, N., Wu, Y.C., Brunet, M., Garrido, C., Chung, F.L., Dai, C., and Mi, L.
(2010). Sulforaphane activates heat shock response and enhances protea-
some activity through up-regulation of Hsp27. J. Biol. Chem. 285, 35528–
35536.
Kansanen, E., Jyrkka¨nen, H.K., Volger, O.L., Leinonen, H., Kivela¨, A.M.,
Ha¨kkinen, S.K., Woodcock, S.R., Schopfer, F.J., Horrevoets, A.J., Yla¨-
Herttuala, S., et al. (2009). Nrf2-dependent and -independent responses to
nitro-fatty acids in human endothelial cells: identification of heat shock
response as the major pathway activated by nitro-oleic acid. J. Biol. Chem.
284, 33233–33241.
Kwak, M.K., Ramos-Gomez, M., Wakabayashi, N., and Kensler, T.W. (2004).
Chemoprevention by 1,2-dithiole-3-thiones through induction of NQO1 and
other phase 2 enzymes. Methods Enzymol. 382, 414–423.
Liby, K., Yore, M.M., Roebuck, B.D., Baumgartner, K.J., Honda, T.,
Sundararajan, C., Yoshizawa, H., Gribble, G.W., Williams, C.R., Risingsong,
R., et al. (2008). A novel acetylenic tricyclic bis-(cyano enone) potently induces
phase 2 cytoprotective pathways and blocks liver carcinogenesis induced by
aflatoxin. Cancer Res. 68, 6727–6733.
Liu, H., Dinkova-Kostova, A.T., and Talalay, P. (2008). Coordinate regulation of
enzyme markers for inflammation and for protection against oxidants and
electrophiles. Proc. Natl. Acad. Sci. USA 105, 15926–15931.
Lu, M., Kim, H.E., Li, C.R., Kim, S., Kwak, I.J., Lee, Y.J., Kim, S.S., Moon, J.Y.,
Kim, C.H., Kim, D.K., et al. (2008). Two distinct disulfide bonds formed in
human heat shock transcription factor 1 act in opposition to regulate its
DNA binding activity. Biochemistry 47, 6007–6015.
Motohashi, H., and Yamamoto, M. (2004). Nrf2-Keap1 defines a physiologi-
cally important stress response mechanism. Trends Mol. Med. 10, 549–557.
Pacher, P., Beckman, J.S., and Liaudet, L. (2007). Nitric oxide and peroxyni-
trite in health and disease. Physiol. Rev. 87, 315–424.
Prochaska, H.J., and Santamaria, A.B. (1988). Direct measurement of NAD(P)
H:quinone reductase from cells cultured in microtiter wells: a screening assay
for anticarcinogenic enzyme inducers. Anal. Biochem. 169, 328–336.Elsevier Ltd All rights reserved
Chemistry & Biology
HSF1-Dependent Activation of Hsp70 by Nrf2 InducerTalalay, P. (2000). Chemoprotection against cancer by induction of phase 2
enzymes. Biofactors 12, 5–11.
Talalay, P., De Long, M.J., and Prochaska, H.J. (1988). Identification of
a common chemical signal regulating the induction of enzymes that protect
against chemical carcinogenesis. Proc. Natl. Acad. Sci. USA 85, 8261–8265.
Trott, A., West, J.D., Klaic, L., Westerheide, S.D., Silverman, R.B., Morimoto,
R.I., and Morano, K.A. (2008). Activation of heat shock and antioxidant
responses by the natural product celastrol: transcriptional signatures of
a thiol-targeted molecule. Mol. Biol. Cell 19, 1104–1112.
Wakabayashi, N., Slocum, S.L., Skoko, J.J., Shin, S., and Kensler, T.W. (2010).
When NRF2 talks, who’s listening? Antioxid. Redox Signal. 13, 1649–1663.Chemistry & Biology 18, 1355–136Westerheide, S.D., and Morimoto, R.I. (2005). Heat shock response modula-
tors as therapeutic tools for diseases of protein conformation. J. Biol. Chem.
280, 33097–33100.
Xiao, X., Zuo, X., Davis, A.A., McMillan, D.R., Curry, B.B., Richardson, J.A., and
Benjamin, I.J. (1999). HSF1 is required for extra-embryonic development,
postnatal growth and protection during inflammatory responses in mice.
EMBO J. 18, 5943–5952.
Yates, M.S., Tran, Q.T., Dolan, P.M., Osburn, W.O., Shin, S., McCulloch, C.C.,
Silkworth, J.B., Taguchi, K., Yamamoto, M., Williams, C.R., et al. (2009).
Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet
distinct gene expression profiles between Keap1 knockout and triterpenoid-
treated mice. Carcinogenesis 30, 1024–1031.1, November 23, 2011 ª2011 Elsevier Ltd All rights reserved 1361
